ChronoScale (CHRN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
CHRN slides 6.0% to $15.08. Closed at $15.08, -6.04% vs the prior close of $16.05. Day range $14.91β$16.01, opened at $15.81.
CHRN daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β CHRN slides 6.0% to $15.08
- Closed at $15.08, -6.04% vs the prior close of $16.05. Day range $14.91β$16.01, opened at $15.81.
- Volume was 124.97K shares, 0.8x its 50-day average of 150.74K.
- Price is -23.8% vs its 50-day average ($19.79) and -3.7% vs its 200-day average ($15.66).
- 52-week range $3.50β$30.00; today's close sits at 44% of that range, 49.7% below the 52-week high.
Oct 15, 2026 β CHRN jumps 7.9% to $16.05 on 2.2x normal volume
- Closed at $16.05, +7.86% vs the prior close of $14.88. Day range $12.62β$16.42, opened at $13.60.
- Volume was 317.80K shares, 2.2x its 50-day average of 146.45K β unusually heavy trading.
- Price is -19.3% vs its 50-day average ($19.90) and +2.7% vs its 200-day average ($15.63).
- 52-week range $3.50β$30.00; today's close sits at 47% of that range, 46.5% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 14, 2026 β CHRN slides 8.8% to $14.88, a 3-month low, 5 down days in a row
- Closed at $14.88, -8.77% vs the prior close of $16.31. Day range $14.77β$16.19, opened at $16.00.
- Volume was 214.80K shares, 1.5x its 50-day average of 147.12K.
- Price is -25.8% vs its 50-day average ($20.04) and -4.5% vs its 200-day average ($15.58).
- 52-week range $3.50β$30.00; today's close sits at 43% of that range, 50.4% below the 52-week high.
- That makes 5 straight losses.
- SEC filings that day: 10-Q.
Oct 13, 2026 β CHRN slides 8.8% to $16.31, a 3-month low on 2.2x normal volume
- Closed at $16.31, -8.78% vs the prior close of $17.88. Day range $15.32β$17.80, opened at $17.80.
- Volume was 310.20K shares, 2.2x its 50-day average of 143.39K β unusually heavy trading.
- Price is -19.4% vs its 50-day average ($20.23) and +5.0% vs its 200-day average ($15.54).
- 52-week range $3.50β$30.00; today's close sits at 48% of that range, 45.6% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 β CHRN slides 3.8% to $17.88, 3 down days in a row
- Closed at $17.88, -3.82% vs the prior close of $18.59. Day range $17.86β$18.49, opened at $18.34.
- Volume was 93.80K shares, 0.7x its 50-day average of 143.79K.
- Price is -12.3% vs its 50-day average ($20.39) and +15.5% vs its 200-day average ($15.48).
- 52-week range $3.50β$30.00; today's close sits at 54% of that range, 40.4% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 β CHRN dips 2.3% to $18.59
- Closed at $18.59, -2.31% vs the prior close of $19.03. Day range $18.21β$19.46, opened at $19.13.
- Volume was 108.20K shares, 0.8x its 50-day average of 144.13K.
- Price is -9.2% vs its 50-day average ($20.47) and +20.6% vs its 200-day average ($15.42).
- 52-week range $3.50β$30.00; today's close sits at 57% of that range, 38.0% below the 52-week high.
Oct 8, 2026 β CHRN slides 3.7% to $19.03
- Closed at $19.03, -3.74% vs the prior close of $19.77. Day range $18.49β$19.88, opened at $19.41.
- Volume was 125.30K shares, 0.9x its 50-day average of 144.31K.
- Price is -7.3% vs its 50-day average ($20.52) and +24.0% vs its 200-day average ($15.35).
- 52-week range $3.50β$30.00; today's close sits at 59% of that range, 36.6% below the 52-week high.
Oct 7, 2026 β CHRN rises 2.5% to $19.77
- Closed at $19.77, +2.54% vs the prior close of $19.28. Day range $18.44β$20.15, opened at $18.44.
- Volume was 123.50K shares, 0.8x its 50-day average of 147.87K.
- Price is -3.6% vs its 50-day average ($20.51) and +29.4% vs its 200-day average ($15.28).
- 52-week range $3.50β$30.00; today's close sits at 61% of that range, 34.1% below the 52-week high.
Oct 6, 2026 β CHRN jumps 3.7% to $19.28
- Closed at $19.28, +3.66% vs the prior close of $18.60. Day range $18.40β$19.56, opened at $18.90.
- Volume was 99.80K shares, 0.7x its 50-day average of 150.73K.
- Price is -6.0% vs its 50-day average ($20.52) and +26.8% vs its 200-day average ($15.21).
- 52-week range $3.50β$30.00; today's close sits at 60% of that range, 35.7% below the 52-week high.
- SEC filings that day: 8-K, S-3.
Oct 5, 2026 β CHRN slides 3.2% to $18.60, 7 down days in a row
- Closed at $18.60, -3.18% vs the prior close of $19.21. Day range $18.32β$19.75, opened at $19.19.
- Volume was 132.10K shares, 0.9x its 50-day average of 151.62K.
- Price is -9.4% vs its 50-day average ($20.54) and +22.9% vs its 200-day average ($15.13).
- 52-week range $3.50β$30.00; today's close sits at 57% of that range, 38.0% below the 52-week high.
- That makes 7 straight losses.
Oct 2, 2026 β CHRN dips 0.8% to $19.21, 6 down days in a row
- Closed at $19.21, -0.83% vs the prior close of $19.37. Day range $19.09β$20.93, opened at $19.97.
- Volume was 155.40K shares, 1.0x its 50-day average of 154.68K.
- Price is -6.7% vs its 50-day average ($20.60) and +27.5% vs its 200-day average ($15.06).
- 52-week range $3.50β$30.00; today's close sits at 59% of that range, 36.0% below the 52-week high.
- That makes 6 straight losses.
- SEC filings that day: 8-K.
CHRN latest news & SEC filings
Every SEC filing by or about CHRN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 Β· Form DEFA14A β Additional proxy materials
Additional proxy materials
Oct 15, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Oct 14, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Aug 31, 2026:
- Revenue: $41.48M (prior year $16.72M) (+148.1% vs Aug 31, 2025)
- Net income: -$42.48M (prior year -$11.24M) (loss widened vs Aug 31, 2025)
- Diluted EPS: -$0.29 (prior year -$0.08) (loss widened vs Aug 31, 2025)
Oct 9, 2026 Β· Form EFFECT β EFFECT filing
EFFECT filing
Oct 6, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Davis Scott G. received an award of 51,626 shares on Oct 2, 2026; now holds 239,760
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 6, 2026 Β· Form S-8 POS β S-8 POS filing
S-8 POS filing
Oct 6, 2026 Β· Form S-8 POS β S-8 POS filing
S-8 POS filing
Oct 6, 2026 Β· Form S-8 POS β S-8 POS filing
S-8 POS filing
Oct 6, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.02 β Change in directors or officers (appointment, departure or pay).
Oct 6, 2026 Β· Form S-8 POS β S-8 POS filing
S-8 POS filing
Oct 6, 2026 Β· Form S-8 POS β S-8 POS filing
S-8 POS filing
Oct 6, 2026 Β· Form S-8 POS β S-8 POS filing
S-8 POS filing
Oct 6, 2026 Β· Form S-8 POS β S-8 POS filing
S-8 POS filing
Oct 6, 2026 Β· Form S-8 POS β S-8 POS filing
S-8 POS filing
Oct 6, 2026 Β· Form S-8 POS β S-8 POS filing
S-8 POS filing
Things to know before you trade CHRN
- Last results release: Oct 15, 2026 (8-K Item 2.02). Previous ones: Feb 17, 2026, Oct 28, 2025, Jul 28, 2025. Based on that rhythm, the next report is likely around Jan 14, 2027 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.07% (largest 9.2%). That is a volatile stock.
- Liquidity: about 141.42K shares (β$2.13M) trade per day on average.
- 52-week position: $15.08 vs a range of $3.50β$30.00 (44% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:15 on Jun 2, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Jason C Jones bought 1,308 shares on Mar 16, 2026.
- Latest filings: 8-K Oct 15, 2026; 10-Q Oct 14, 2026; 8-K Oct 6, 2026.
- Share count: 145.64M shares outstanding (Oct 13, 2026), +5451.8% vs a year earlier β notable dilution.
- Listing: Nasdaq Β· industry: General Industrial Machinery & Equipment, NEC.
CHRN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 15.81 | 16.01 | 14.91 | 15.08 | 124.97K |
| Oct 15, 2026 | 13.60 | 16.42 | 12.62 | 16.05 | 317.80K |
| Oct 14, 2026 | 16.00 | 16.19 | 14.77 | 14.88 | 214.80K |
| Oct 13, 2026 | 17.80 | 17.80 | 15.32 | 16.31 | 310.20K |
| Oct 12, 2026 | 18.34 | 18.49 | 17.86 | 17.88 | 93.80K |
| Oct 9, 2026 | 19.13 | 19.46 | 18.21 | 18.59 | 108.20K |
| Oct 8, 2026 | 19.41 | 19.88 | 18.49 | 19.03 | 125.30K |
| Oct 7, 2026 | 18.44 | 20.15 | 18.44 | 19.77 | 123.50K |
| Oct 6, 2026 | 18.90 | 19.56 | 18.40 | 19.28 | 99.80K |
| Oct 5, 2026 | 19.19 | 19.75 | 18.32 | 18.60 | 132.10K |
| Oct 2, 2026 | 19.97 | 20.93 | 19.09 | 19.21 | 155.40K |
| Oct 1, 2026 | 19.73 | 20.22 | 18.75 | 19.37 | 96.40K |
| Sep 30, 2026 | 19.64 | 20.42 | 19.50 | 19.73 | 67.10K |
| Sep 29, 2026 | 20.04 | 20.33 | 18.94 | 19.75 | 77.90K |
| Sep 28, 2026 | 19.51 | 20.20 | 19.00 | 19.82 | 92.80K |
| Sep 25, 2026 | 21.99 | 21.99 | 19.65 | 19.85 | 169.00K |
| Sep 24, 2026 | 20.27 | 22.58 | 20.27 | 21.85 | 169.80K |
| Sep 23, 2026 | 21.35 | 21.78 | 20.00 | 20.51 | 75.20K |
| Sep 22, 2026 | 21.54 | 22.39 | 21.12 | 21.20 | 153.60K |
| Sep 21, 2026 | 20.76 | 21.85 | 20.54 | 21.69 | 120.80K |
About ChronoScale
ChronoScale (CHRN) is listed on the Nasdaq and classified by the SEC under βGeneral Industrial Machinery & Equipment, NECβ. Its business address is in MENLO PARK, CA. Fiscal year ends May 31. SEC CIK 1549084.
CHRN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Ella G. Benson | Director | May 18, 2026 |
| William M Clancy | Director | May 18, 2026 |
| Ying Cenly Chen | Chief Executive Officer | Jul 15, 2026 |
| Wes Cummins | Director | May 18, 2026 |
| Scott G. Davis | Director | May 18, 2026 |
| Douglas S Miller | Director | May 18, 2026 |
| Richard N Nottenburg | Director | May 18, 2026 |
| Andrew Cordell Schaap | Director | Jun 30, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ying Cenly Chen | Chief Executive Officer | Jul 15, 2026 |
| Rajasekar Jegannathan | Chief Technology Officer | Jul 24, 2026 |
| Jason C Jones | Chief Operating Officer | Mar 20, 2026 |
| Jerome Wong | Chief Financial Officer | Aug 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 16, 2026 | Jason C Jones | Buy | 1,308 | $11.85 |
| Mar 16, 2026 | Jason C Jones | Buy | 1,308 | $11.85 |
| Mar 16, 2026 | Jason C Jones | Buy | 1,308 | $11.85 |
| Mar 16, 2026 | Jason C Jones | Buy | 1,308 | $11.85 |
| Mar 16, 2026 | Jerome Wong | Buy | 1,308 | $11.85 |
| Mar 16, 2026 | Jerome Wong | Buy | 1,308 | $11.85 |
| Mar 16, 2026 | Jerome Wong | Buy | 1,308 | $11.85 |
| Mar 16, 2026 | Jerome Wong | Buy | 1,308 | $11.85 |
| Feb 19, 2026 | Daniel Asher | Buy | 15,540 | $12.30 |
| Feb 19, 2026 | Daniel Asher | Buy | 15,540 | $12.30 |
| Feb 19, 2026 | Daniel Asher | Buy | 15,540 | $12.30 |
| Feb 19, 2026 | Daniel Asher | Buy | 15,540 | $12.30 |
| Feb 19, 2026 | Daniel Asher | Buy | 1,200 | $9.60 |
| Feb 19, 2026 | Daniel Asher | Buy | 1,200 | $9.60 |
| Feb 19, 2026 | Daniel Asher | Buy | 1,200 | $9.60 |
CHRN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| May 31, 2026 | $71.60M | $-50.32M | -0.36 | $39.07M |
| Dec 31, 2025 | β | $-11.70M | -4.91 | $-11.80M |
| May 31, 2025 | $84.38M | $-72.73M | -0.53 | $-7.22M |
| Dec 31, 2024 | β | $-11.33M | -8.43 | $-9.85M |
| Dec 31, 2023 | β | $-15.20M | -1.10 | $-12.05M |
Latest balance sheet: total assets $295.40M, total liabilities $144.75M, cash $15.22M (as of Aug 31, 2026).
CHRN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 15, 2026 | 8-K Item 2.02 (results) | $16.05 |
| Feb 17, 2026 | 8-K Item 2.02 (results) | $11.15 |
| Oct 28, 2025 | 8-K Item 2.02 (results) | $4.81 |
| Jul 28, 2025 | 8-K Item 2.02 (results) | $4.53 |
| May 5, 2025 | 8-K Item 2.02 (results) | $7.14 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $7.23 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $10.68 |
| Oct 28, 2024 | 8-K Item 2.02 (results) | $16.95 |
| Jul 29, 2024 | 8-K Item 2.02 (results) | β |
| Apr 29, 2024 | 8-K Item 2.02 (results) | β |
| Mar 4, 2024 | 8-K Item 2.02 (results) | β |
| Jan 5, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· General Industrial Machinery & Equipment, NEC
Regal Rexnord (RRX)Nordson (NDSN)Ouster (OUST)Esab (ESAB)Symbotic (SYM)Churchill Capital Corp XI (CCXI)Hesai (HSAI)Inlif (INLF)Serve Robotics (SERV)Richtech Robotics (RR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CHRN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.